196 studies found for:    Open Studies | "Protozoan Infections"
Show Display Options
Rank Status Study
1 Unknown  Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
Conditions: Trypanosomiasis;   Trypanosomiasis, African;   Protozoan Infections;   Parasitic Diseases
Interventions: Drug: SCYX-7158;   Drug: Placebo
2 Unknown  Babesia Testing in Blood Donors
Condition: Transfusion Transmitted Babesiosis
Intervention: Biological: B.microti diagnostic blood tests
3 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
4 Recruiting Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events
Conditions: HIV;   Malnutrition;   Cryptosporidiosis
Intervention:
5 Not yet recruiting Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter
6 Recruiting Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Condition: Congenital Toxoplasmosis
Interventions: Drug: Pyrimethamine/Sulfadiazine;   Drug: Spiramycine
7 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
8 Recruiting Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment
9 Recruiting Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children
Condition: Cerebral Malaria
Interventions: Drug: inhaled nitric oxide;   Drug: Placebo
10 Recruiting A Dose-Escalation, Safety and Feasibility Study of Enteral Levetiracetam for Seizure Control in Pediatric Cerebral Malaria
Conditions: Seizure;   Epilepsy;   Cerebral Malaria
Interventions: Drug: Oral Levetiracetam;   Drug: Standard AED
11 Unknown  Randomized Trial of Erythropoietin During Cerebral Malaria
Condition: Cerebral Malaria
Interventions: Drug: Placebo;   Drug: Erythropoietin
12 Recruiting Introduction of Eurartesim® in Burkina Faso, Mozambique, Ghana and Tanzania
Condition: Malaria
Intervention: Drug: Dihydroartemisinin and piperaquine
13 Unknown  Phase Ib Trial of MSP3 LSP in Children in Tanzania
Condition: Malaria
Interventions: Biological: MSP 3 Long Synthetic Peptide;   Biological: MSP3 vaccine;   Biological: Hepatitis B vaccine;   Biological: MSP3 candidate vaccine;   Biological: Hepatitis B control vaccine
14 Recruiting Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
Conditions: Visceral Leishmaniasis;   Human African Trypanosomiasis;   Enteric Fever;   Melioidosis;   Brucellosis;   Leptospirosis;   Relapsing Fever;   Rickettsial Diseases;   HIV;   Tuberculosis;   Malaria;   Amoebic Liver Abscess
Interventions: Device: rk28 ICT;   Device: IT LEISH (rK39);   Device: Immunochromatographic HAT test;   Device: HAT Serostrip;   Device: Card Agglutination Trypanosoma Test (CATT)-10;   Device: Typhidot M;   Device: S. typhi IgM/IgG;   Device: Test-it Typhoid IgM;   Device: Test-it Leptospirosis IgM;   Device: Leptospira IgG/IgM
15 Unknown  Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Condition: Trichomonas Infections
Intervention:
16 Recruiting Chloroquine for Malaria in Pregnancy
Condition: Malaria
Interventions: Drug: sulfadoxine/pyrimethamine;   Drug: Chloroquine
17 Recruiting Adherence to Antimalarial Drugs in Sierra Leone
Condition: Malaria
Interventions: Drug: amodiaquine-artesunate (AQAS) co-formulated;   Drug: Artemether-lumefantrine combination (AL)
18 Unknown  Human Immunity to MSP-1 in Western Kenya
Condition: Plasmodium Falciparum Malaria
Intervention:
19 Recruiting Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in Pregnancy
Condition: Malaria
Interventions: Drug: dihydroartemisinin-piperaquine;   Drug: Artesunate-mefloquine;   Drug: arthemeter-lumefantrin
20 Recruiting Auranofin PK Following Oral Dose Administration
Condition: Amoebiasis
Intervention: Drug: Auranofin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years